{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T18:06:45Z","timestamp":1784225205763,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,3,19]],"date-time":"2017-03-19T00:00:00Z","timestamp":1489881600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.ymgmr.2017.03.004","type":"journal-article","created":{"date-parts":[[2017,3,25]],"date-time":"2017-03-25T06:45:19Z","timestamp":1490424319000},"page":"8-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Chronic intestinal pseudo-obstruction. Did you search for lysosomal storage diseases?"],"prefix":"10.1016","volume":"11","author":[{"given":"J.","family":"Politei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.B.","family":"Schenone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Mukdsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.L.","family":"Thurberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ymgmr.2017.03.004_bb0005","doi-asserted-by":"crossref","first-page":"292","DOI":"10.4321\/S1130-01082006000400007","article-title":"Chronic primary intestinal pseudo-obstruction from visceral myopathy","volume":"98","author":"Mu\u00f1oz-Yag\u00fce","year":"2006","journal-title":"Rev. Esp. Enferm. Dig."},{"key":"10.1016\/j.ymgmr.2017.03.004_bb0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/gut.28.1.5","article-title":"Chronic idiopathic intestinal pseudo-obstruction: clinical and intestinal manometric findings","volume":"28","author":"Stanghellini","year":"1987","journal-title":"Gut"},{"key":"10.1016\/j.ymgmr.2017.03.004_bb0015","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S0016-5085(99)70082-X","article-title":"Pseudo-obstruction: current approaches","volume":"116","author":"Di Lorenzo","year":"1999","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.ymgmr.2017.03.004_bb0020","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/cge.12673","article-title":"Gastrointestinal involvement in Fabry disease. So important, yet often neglected","volume":"89","author":"Politei","year":"2016","journal-title":"Clin. Genet."},{"issue":"33","key":"10.1016\/j.ymgmr.2017.03.004_bb0025","doi-asserted-by":"crossref","first-page":"5972","DOI":"10.2174\/1381612811319330016","article-title":"Anderson Fabry disease: a multiorgan metabolic disease susceptible of treatment","volume":"19","author":"Tuttolomondo","year":"2013","journal-title":"Curr. Pharm. Des."},{"issue":"33","key":"10.1016\/j.ymgmr.2017.03.004_bb0030","doi-asserted-by":"crossref","first-page":"6014","DOI":"10.2174\/13816128113199990387","article-title":"Neurological complications of Anderson-Fabry disease","volume":"19","author":"Tuttolomondo","year":"2013","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"10.1016\/j.ymgmr.2017.03.004_bb0035","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jpeds.2013.01.031","article-title":"Identification of infants at risk for developing Fabry, Pompe, or mucopolysaccharidosis-I from newborn blood spots by tandem mass spectrometry","volume":"163","author":"Scott","year":"2013","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgmr.2017.03.004_bb0040","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1136\/gut.2004.043968","article-title":"Advances in our understanding of the pathology of chronic intestinal pseudo-obstruction","volume":"53","author":"De Giorgio","year":"2004","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.ymgmr.2017.03.004_bb0045","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s10545-007-0521-2","article-title":"Fabry disease: baseline medical characteristics of a cohort of 1765 males and females in the Fabry registry","volume":"30","author":"Eng","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"issue":"12","key":"10.1016\/j.ymgmr.2017.03.004_bb0050","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.cgh.2007.08.012","article-title":"Fabry outcome survey European investigators. Gastrointestinal symptoms in 342 patients with Fabry disease: prevalence and response to enzyme replacement therapy","volume":"5","author":"Hoffmann","year":"2007","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"33","key":"10.1016\/j.ymgmr.2017.03.004_bb0055","doi-asserted-by":"crossref","first-page":"6009","DOI":"10.2174\/13816128113199990347","article-title":"Gastroenterological complications of Anderson-Fabry disease","volume":"19","author":"Buda","year":"2013","journal-title":"Curr. Pharm. Des."},{"issue":"5","key":"10.1016\/j.ymgmr.2017.03.004_bb0060","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/gim.2014.120","article-title":"Fabry disease in infancy and early childhood: a systematic literature review","volume":"17","author":"Laney","year":"2015","journal-title":"Genet. Med."},{"issue":"11","key":"10.1016\/j.ymgmr.2017.03.004_bb0065","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00431-003-1299-3","article-title":"The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents","volume":"162","author":"Ries","year":"2003","journal-title":"Eur. J. Pediatr."},{"issue":"12","key":"10.1016\/j.ymgmr.2017.03.004_bb0070","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.cgh.2007.08.012","article-title":"Fabry outcome survey European investigators. Gastrointestinal symptoms in 342 patients with Fabry disease: prevalence and response to enzyme replacement therapy","volume":"5","author":"Hoffmann","year":"2007","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.ymgmr.2017.03.004_bb0075","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0016-5085(84)80028-1","article-title":"Jejunal diverticulosis with perforation as a complication of Fabry's disease","volume":"86","author":"Friedman","year":"1984","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.ymgmr.2017.03.004_bb0080","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1440-1746.1994.tb01244.x","article-title":"Small bowel ischaemia in Fabry's disease","volume":"9","author":"Jardine","year":"1994","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"788","key":"10.1016\/j.ymgmr.2017.03.004_bb0085","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/pgmj.67.788.584","article-title":"Colonic involvement in Fabry's disease","volume":"67","author":"Jack","year":"1991","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.ymgmr.2017.03.004_bb0090","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1471-2377-11-61","article-title":"Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel","volume":"11","author":"Burlina","year":"2011","journal-title":"BMC Neurol."},{"issue":"2","key":"10.1016\/j.ymgmr.2017.03.004_bb0095","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/ki.2014.399","article-title":"Appendiceal tissue confirmation of Fabry's disease","volume":"88","author":"Wallace","year":"2015","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.ymgmr.2017.03.004_bb0100","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1177\/1066896911428737","article-title":"Colonic involvement in Fabry disease","volume":"19","author":"Deniz","year":"2011","journal-title":"Int. J. Surg. Pathol."},{"issue":"5","key":"10.1016\/j.ymgmr.2017.03.004_bb0105","doi-asserted-by":"crossref","first-page":"628","DOI":"10.7326\/0003-4819-81-5-628","article-title":"Intestinal manifestations of Fabry's disease","volume":"81","author":"Rowe","year":"1974","journal-title":"Ann. Intern. Med."},{"issue":"5","key":"10.1016\/j.ymgmr.2017.03.004_bb0110","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0016-5085(82)80262-X","article-title":"Pathophysiologic and ultrastructural basis for intestinal symptoms in Fabry's disease","volume":"82","author":"O'Brien","year":"1982","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.ymgmr.2017.03.004_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108641","article-title":"Pain related channels are differentially expressed in neuronal and non-neuronal cells of glabrous skin of Fabry knockout male mice","volume":"9","author":"Lakom\u00e1","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgmr.2017.03.004_bb0120","doi-asserted-by":"crossref","DOI":"10.1177\/1744806916663729","article-title":"Increased expression of Trpv1 in peripheral terminals mediates thermal nociception in Fabry disease mouse model","volume":"12","author":"Lakom\u00e1","year":"2016","journal-title":"Mol. Pain"},{"issue":"9","key":"10.1016\/j.ymgmr.2017.03.004_bb0125","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.3390\/ph3092768","article-title":"Identifying the ion channels responsible for signaling gastro-intestinal based pain","volume":"3","author":"Brierley","year":"2010","journal-title":"Pharmaceuticals (Basel)"},{"issue":"2","key":"10.1016\/j.ymgmr.2017.03.004_bb0130","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ymgme.2015.10.007","article-title":"Fabry pediatric expert panel. The management and treatment of children with Fabry disease: a United States-based perspective","volume":"117","author":"Hopkin","year":"2016","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"10.1016\/j.ymgmr.2017.03.004_bb0135","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1023\/B:BOLI.0000037342.59612.69","article-title":"Relief of gastrointestinal symptoms under enzyme replacement therapy in patients with Fabry disease","volume":"27","author":"Dehout","year":"2004","journal-title":"J. Inherit. Metab. Dis."},{"issue":"4","key":"10.1016\/j.ymgmr.2017.03.004_bb0140","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jpeds.2007.09.007","article-title":"Safety and efficacy of enzyme replacement therapy with agalsidase beta: an international, open-label study in pediatric patients with Fabry disease","volume":"152","author":"Wraith","year":"2008","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.ymgmr.2017.03.004_bb0145","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1399-0004.2012.01947.x","article-title":"Fabry disease in children: agalsidase-beta enzyme replacement therapy","volume":"83","author":"Borgwardt","year":"2013","journal-title":"Clin. Genet."},{"issue":"1","key":"10.1016\/j.ymgmr.2017.03.004_bb0150","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human alpha-galactosidase A-replacement therapy in Fabry's disease","volume":"345","author":"Eng","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.ymgmr.2017.03.004_bb0155","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease: a randomized controlled trial","volume":"285","author":"Schiffmann","year":"2001","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ymgmr.2017.03.004_bb0160","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1517\/14712598.4.7.1167","article-title":"Enzyme replacement therapy for Fabry disease: lessons from two alpha-galactosidase A orphan products and one FDA approval","volume":"4","author":"Desnick","year":"2004","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"1","key":"10.1016\/j.ymgmr.2017.03.004_bb0165","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1681\/ASN.2012030316","article-title":"Agalsidase benefits renal histology in young patients with Fabry disease","volume":"24","author":"T\u00f8ndel","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ymgmr.2017.03.004_bb0170","article-title":"Reaccumulation of globotriaosylceramide in podocytes after agalsidase dose reduction in young Fabry patients","author":"Skrunes","year":"2016","journal-title":"Nephrol. Dial. Transplant."},{"issue":"4","key":"10.1016\/j.ymgmr.2017.03.004_bb0175","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1681\/ASN.2013060585","article-title":"Patients with Fabry disease after enzyme replacement therapy dose reduction versus treatment switch","volume":"25","author":"Weidemann","year":"2014","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426917300319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426917300319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:49:36Z","timestamp":1762001376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426917300319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":35,"alternative-id":["S2214426917300319"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2017.03.004","relation":{},"ISSN":["2214-4269"],"issn-type":[{"value":"2214-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic intestinal pseudo-obstruction. Did you search for lysosomal storage diseases?","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2017.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}